The Positive Feedback Regulation of NF-κB/miR-21c/IL-9 Axis in Septic Acute Kidney Injury

Zheng Li1, Juan Wang2, Lei Zhang1

  • 1Department of Nephrology, The Second Xiangya Hospital at Central South University, Hunan Key Laboratory of Kidney Disease and Blood Purification, Changsha, Hunan, China.

Kidney360
|May 22, 2026
PubMed
Abstract

Insights

A novel NF-κB/miR-21c/IL-9 feedback loop drives kidney inflammation and injury in sepsis-associated acute kidney injury (septic AKI). Targeting miR-21c or boosting IL-9 may offer new therapies for septic AKI.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Immunology

Background:

  • Sepsis-associated acute kidney injury (septic AKI) is a major cause of death in critically ill patients.
  • Current treatments for septic AKI are limited due to poor understanding of the underlying molecular mechanisms.
  • Renal inflammation and tubular damage are key pathological features of septic AKI.

Purpose of the Study:

  • To elucidate the molecular mechanisms driving renal inflammation and injury in septic AKI.
  • To identify potential therapeutic targets for mitigating kidney damage in septic AKI.

Main Methods:

  • Utilized a murine model of LPS-induced septic AKI and cultured proximal tubular cells.
  • Investigated the role of miR-21c and its regulation by NF-κB.
  • Assessed the interaction between miR-21c and interleukin-9 (IL-9) using molecular biology techniques.
  • Evaluated the effects of modulating miR-21c and IL-9 on kidney function and injury markers.

Main Results:

  • miR-21c was upregulated in septic AKI kidneys, driven by NF-κB activation.
  • Inhibition of miR-21c attenuated kidney injury, reduced inflammation, and decreased tubular apoptosis.
  • miR-21c directly targeted IL-9, and IL-9 restoration suppressed LPS-induced injury.
  • IL-9 overexpression inhibited NF-κB p65 phosphorylation, suggesting a feedback loop.

Conclusions:

  • Identified a pathogenic NF-κB/miR-21c/IL-9 feedback loop that exacerbates septic AKI.
  • Targeting miR-21c or enhancing IL-9 signaling presents promising therapeutic strategies for septic AKI.
  • This discovery could lead to improved treatment outcomes for patients with septic AKI.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...